Race

Cox-2 Inhibitors (nonsteroidal anti-inflammatory drug (NSAID) Agents) (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,353 -
Yes - - 267 -
Unknown - - 460 -
Cox-2 Inhibitors (nonsteroidal anti-inflammatory drug (NSAID) Agents) (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender of the participant
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,562 1,791 3,353
Yes 99 168 267
Unknown 200 260 460
Cox-2 Inhibitors (nonsteroidal anti-inflammatory drug (NSAID) Agents) (Sleep Heart Health Study Visit Two (SHHS2)) vs Race of the participant
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 2,927 223 203 3,353
Yes 235 19 13 267
Unknown 425 14 21 460